Skip to main content
. 2015 Jan 9;56(1):150–155. doi: 10.1167/iovs.14-15382

Table. .

Clinical Features of Patients With NEUROD1 Mutations


Proband
Proband's Affected Sister
Sex/age M/33* F/40*
Age of onset 18 10
BCVA, OD/OS 0.6/0.6 0.1/0.15
Anterior segment NA Dense subcapsular cataract
Fundus Bone-spicule pigmentation in the mid-periphery Diffused RPE and choroidal atrophy with bone-spicule pigmentation
OCT Increased retinal thickness in the macular region with discontinuous IS/OS junction No clear image because of cataract
VF Loss of upper and temporal visual field NA
ERG Moderately decreased rod and cone responses Nonrecordable
BMI 20.2 18.4
FBG, mmol/L 5.4 5.1
HbA1c, % 6.5 6.2
Neurological abnormality
 Developmental delay No No
 Ataxia No No
 Sensorineural deafness No No
 Seizure No No

VF, visual field; BMI, body mass index; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin.

*

All of the ophthalmic and neurological clinical data were taken at age 33 and 40, respectively. BMI, FBG, and HbA1c were taken 2 years later.